Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF.
作者信息
Walker Woolf, Connett Gary
机构信息
Regional Cystic Fibrosis Unit, Southampton Hospitals NHS Trust, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK.
出版信息
J R Soc Med. 2010 Jul;103 Suppl 1(Suppl 1):S27-9. doi: 10.1258/jrsm.2010.s11007.
Abstract
摘要
相似文献
1
Manifesting carriage of a Duchenne muscular dystrophy mutation: an unusual cause of impaired lung function in CF.
J R Soc Med. 2010 Jul;103 Suppl 1(Suppl 1):S27-9. doi: 10.1258/jrsm.2010.s11007.
2
Duchenne gene carrier as cause of asymptomatic hyperckemia.
Arq Neuropsiquiatr. 2008 Jun;66(2B):425-7. doi: 10.1590/s0004-282x2008000300032.
3
Duchenne muscular dystrophy diagnostics: it only gets better but some of the same challenges remain.
Clin Chem. 2015 Jun;61(6):792-3. doi: 10.1373/clinchem.2015.240697. Epub 2015 Apr 7.
4
Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier.
J Neurol. 2009 Feb;256(2):283-4. doi: 10.1007/s00415-009-0055-7. Epub 2009 Feb 27.
5
Analysis of dinucleotide repeat loci of dystrophin gene for carrier detection, germline mosaicism and de novo mutations in Duchenne muscular dystrophy.
Clin Genet. 2000 Sep;58(3):234-6. doi: 10.1034/j.1399-0004.2000.580312.x.
6
DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene.
Neuromuscul Disord. 2002 Nov;12(9):845-8. doi: 10.1016/s0960-8966(02)00069-x.
7
A newly discovered case of progressive muscular dystrophy caused by exon deletion mutation of Duchenne muscular dystrophy gene 12-28.
J Biol Regul Homeost Agents. 2019 Nov-Dec;33(6):1765-1767. doi: 10.23812/19-124-L.
8
DMD and West syndrome.
Neuromuscul Disord. 2017 Oct;27(10):911-913. doi: 10.1016/j.nmd.2017.07.008. Epub 2017 Jul 19.
9
On the edge of noncompaction: minimally manifesting Duchenne carrier due to the dystrophin mutation n.2867A>C.
Int J Cardiol. 2013 May 10;165(2):e18-20. doi: 10.1016/j.ijcard.2012.10.075. Epub 2012 Nov 22.
10
Denaturing HPLC coupled with multiplex PCR for rapid detection of large deletions in Duchenne muscular dystrophy carriers.
Clin Chem. 2005 Jul;51(7):1252-6. doi: 10.1373/clinchem.2004.046144.
本文引用的文献
1
Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.
PLoS Genet. 2009 Jul;5(7):e1000586. doi: 10.1371/journal.pgen.1000586. Epub 2009 Jul 31.
2
Cystic fibrosis.
BMJ. 2007 Dec 15;335(7632):1255-9. doi: 10.1136/bmj.39391.713229.AD.
3
Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests.
Thorax. 2007 Apr;62(4):341-7. doi: 10.1136/thx.2006.068262. Epub 2006 Nov 22.
4
107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands.
Neuromuscul Disord. 2003 Feb;13(2):166-72. doi: 10.1016/s0960-8966(02)00213-4.
5
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study.
Lancet. 1999 Jun 19;353(9170):2116-9. doi: 10.1016/s0140-6736(98)10028-4.
6
Inspiratory muscle function and body composition in cystic fibrosis.
Am J Respir Crit Care Med. 1998 Oct;158(4):1271-6. doi: 10.1164/ajrccm.158.4.9710079.
7
Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy.
Arch Phys Med Rehabil. 1997 Jan;78(1):1-6. doi: 10.1016/s0003-9993(97)90001-0.
8
The female carrier of Duchenne muscular dystrophy.
Br Med J (Clin Res Ed). 1982 May 15;284(6327):1423-4. doi: 10.1136/bmj.284.6327.1423.
9
Manifesting carrier of Becker muscular dystrophy (BMD): clinical and recombinant DNA studies.
Acta Neurol Scand. 1989 Jun;79(6):500-3. doi: 10.1111/j.1600-0404.1989.tb03821.x.
10
A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
Clin Genet. 1989 Jul;36(1):31-7. doi: 10.1111/j.1399-0004.1989.tb03363.x.
Zotero 插件